
Neuronetics STIM
$ 1.28
-1.54%
Quarterly report 2026-Q1
added 05-05-2026
Neuronetics Depreciation & Amortization 2011-2026 | STIM
Annual Depreciation & Amortization Neuronetics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.46 M | 2.07 M | 2.01 M | 1.65 M | 1.06 M | 941 K | 1.06 M | 882 K | 596 K | 673 K | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.46 M | 596 K | 1.44 M |
Quarterly Depreciation & Amortization Neuronetics
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 745 K | - | 500 K | 500 K | 911 K | - | 500 K | 600 K | 560 K | - | 500 K | 500 K | 516 K | - | 400 K | 300 K | 319 K | - | 768 K | 300 K | 281 K | - | 741 K | 534 K | 301 K | - | 765 K | 457 K | 204 K | - | 671 K | 463 K | 139 K | - | 455 K | 307 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 911 K | 139 K | 490 K |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Co-Diagnostics
CODX
|
1.11 M | $ 1.29 | -21.17 % | $ 1.72 M | ||
|
Agilent Technologies
A
|
321 M | $ 111.7 | -1.36 % | $ 34 B | ||
|
Castle Biosciences
CSTL
|
40.8 M | $ 19.13 | 1.32 % | $ 555 M | ||
|
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M | ||
|
Fulgent Genetics
FLGT
|
24.9 M | $ 15.7 | -3.03 % | $ 475 M | ||
|
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | ||
|
Illumina
ILMN
|
354 M | $ 142.54 | -0.49 % | $ 22.7 B | ||
|
Interpace Biosciences
IDXG
|
425 K | $ 1.76 | -2.22 % | $ 7.79 M | ||
|
CareDx, Inc
CDNA
|
15 M | $ 19.97 | -2.54 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | ||
|
Lantheus Holdings
LNTH
|
70.1 M | $ 93.91 | -2.86 % | $ 6.34 B | ||
|
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
27.2 M | $ 415.27 | -0.93 % | $ 12 B | ||
|
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
51.1 M | $ 1 031.64 | -0.99 % | $ 21.3 B | ||
|
Myriad Genetics
MYGN
|
53.7 M | $ 3.58 | -1.1 % | $ 332 M | ||
|
NeoGenomics
NEO
|
36.1 M | $ 8.24 | -1.44 % | $ 1.06 B | ||
|
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
7.62 M | $ 18.62 | -1.64 % | $ 417 M | ||
|
Charles River Laboratories International
CRL
|
403 M | $ 150.85 | -5.3 % | $ 7.48 B | ||
|
Natera
NTRA
|
16.7 M | $ 186.36 | -5.36 % | $ 18.3 B | ||
|
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | ||
|
Koninklijke Philips N.V.
PHG
|
1.12 B | $ 25.23 | -1.06 % | $ 23.9 B | ||
|
Guardant Health
GH
|
39.7 M | $ 94.92 | -3.79 % | $ 11.9 B | ||
|
Personalis
PSNL
|
10 M | $ 6.36 | -5.22 % | $ 568 M | ||
|
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
488 M | $ 116.38 | -0.61 % | $ 9.6 B | ||
|
Senseonics Holdings
SENS
|
1.51 M | $ 5.77 | -0.86 % | $ 241 M | ||
|
Soleno Therapeutics
SLNO
|
2.02 M | $ 53.01 | 0.04 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
87 K | $ 2.34 | -2.9 % | $ 5.38 M | ||
|
Laboratory Corporation of America Holdings
LH
|
681 M | $ 250.4 | -1.43 % | $ 20.8 B | ||
|
Thermo Fisher Scientific
TMO
|
1.05 B | $ 438.34 | -2.2 % | $ 165 B | ||
|
Celcuity
CELC
|
167 K | $ 137.68 | 2.2 % | $ 6.44 B | ||
|
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
24.9 M | $ 49.17 | -7.14 % | $ 2.94 B | ||
|
Neogen Corporation
NEOG
|
119 M | $ 8.19 | -2.85 % | $ 1.78 B | ||
|
Quest Diagnostics Incorporated
DGX
|
570 M | $ 186.61 | -0.71 % | $ 20.7 B | ||
|
Invitae Corporation
NVTA
|
142 M | - | - | $ 21.2 M |